Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirija Ranjit Anderson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Australian Journal of General Practice|November 28, 2019
Heart on the wrong sideJohn O'Bryen, Nirija Ranjit Anderson, Joel Collins
Blood|July 15, 2025
Visualizing amyloidosis: the role of radionuclide imaging in systemic amyloidosisNirija Ranjit Anderson, Sharmila Dorbala, Peter Mollee
Expert Review of Hematology|August 19, 2024
Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?Nirija Ranjit Anderson, Dariusz Korczyk, Peter Mollee
Internal Medicine Journal|February 22, 2026
An Australian Amyloidosis Network analysis of Australian patients with immunoglobulin light chain amyloidosis treated with bortezomib-based chemotherapyAnthea Gibbons, Lipi Chakravorty, Hasib Sidiqi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Australian Journal of General Practice|November 28, 2019
Heart on the wrong sideJohn O'Bryen, Nirija Ranjit Anderson, Joel Collins
Blood|July 15, 2025
Visualizing amyloidosis: the role of radionuclide imaging in systemic amyloidosisNirija Ranjit Anderson, Sharmila Dorbala, Peter Mollee
Expert Review of Hematology|August 19, 2024
Improving care for systemic light-chain amyloidosis patients: is a multidisciplinary approach best?Nirija Ranjit Anderson, Dariusz Korczyk, Peter Mollee
Internal Medicine Journal|February 22, 2026
An Australian Amyloidosis Network analysis of Australian patients with immunoglobulin light chain amyloidosis treated with bortezomib-based chemotherapyAnthea Gibbons, Lipi Chakravorty, Hasib Sidiqi, et al.
Pageof 1